Biologic drugs are highly complex, but they may be the answer to many medical illnesses and conditions that currently have no treatment available. The problem is, these drugs are not easy to characterize and test. Unlike ...
Jun 11, 2014
0
0
A series of research articles published ahead of print in the journal Antimicrobial Agents and Chemotherapy have identified a number of existing pharmaceutical drugs and compounds under development that may offer effective ...
May 19, 2014
0
0
Health systems worldwide are increasingly negotiating secret price rebates from pharmaceutical companies and Canadians risk losing out on the deal.
Apr 8, 2013
0
0
The first product to hit the Swiss market from Empa and ETH Zurich spin-off compliant concept is surpassing all expectations. The successful market launch of the electronic healthcare assistant also impressed investors. Following ...
Jan 17, 2013
0
0
(AP)—A Japanese pharmaceutical company is acquiring LigoCyte Pharmaceuticals in a $60 million deal to expand its vaccine division, Takeda Pharmaceutical Co. announced.
Oct 5, 2012
0
0
(AP)—Valeant Pharmaceuticals International Inc. has agreed to buy dermatology products maker Medicis Pharmaceutical Corp. for about $2.6 billion in cash in a deal to strengthen its position in skin treatments and care.
Sep 3, 2012
0
0
In open source drug discovery all data and ideas are freely and immediately shared, and anyone may participate at any level.
Mar 9, 2012
0
0
South Africa on Friday unveiled plans for a 1.6 billion rand ($208 million, 157 million euro) pharmaceutical plant, in a joint venture with Swiss biochemicals group Lonza to produce anti-AIDS drugs.
Feb 10, 2012
0
0
The study identifies the respective contributions of direct and indirect government support in research and development of new pharmaceutical drugs.
Dec 15, 2011
0
0
